How to Create a Ketamine Compliance Program

This article was written in partnership with SimiTree, a leading solution to align your organizational initiatives with your patients’ wellbeing.

Ketamine therapy is revolutionizing the treatment of certain mental health conditions — especially for individuals who have not responded to traditional medications. With its rapid-acting benefits and potential to reduce suicidality, ketamine is becoming an increasingly important tool in behavioral healthcare. However, as its use expands, so do the challenges of ensuring patient safety, regulatory compliance, and ethical administration.

Despite its effectiveness, ketamine therapy requires careful oversight. The rise of at-home ketamine delivery services and inconsistent adherence to medical guidelines present risks, including misuse, dependency, and adverse side effects. To protect patients and ensure the long-term viability of ketamine treatment, behavioral health providers must implement structured compliance programs that prioritize safety, monitoring, and adherence to regulatory standards.

Quick overview of ketamine therapy

Ketamine therapy is emerging as a transformative option for treatment-resistant depression, anxiety, post-traumatic stress disorder (PTSD), and, in some cases, addiction. As behavioral health providers seek solutions for patients who do not respond to traditional interventions, ketamine offers relief and a new avenue for care.

Ketamine can be administered through intravenous (IV) infusions, troches (sublingual), creams for pain management, and nasal spray. These options have proven effective in clinical trials, however, IV infusions take 40-60 minutes to complete. For patients with conditions that would make this length of treatment unrealistic or who have an aversion to needles, the nasal spray option may be better. Also known by its prescription name, Spravato, this is only current FDA-approved option. An esketamine-based prescription medication, nasal sprays can be more accessible, often covered by insurance and used in Veterans’ programs.

Despite its benefits, ketamine therapy requires careful screening and monitoring. Its dissociative effects and potential for misuse make it risky for patients with a history of substance use disorders. As such, providers performing IV infusions must administer ketamine therapy on-site and make sure the patient meets certain conditions, namely:

• Traditional medications (e.g., SSRIs) have proven ineffective.
• They are not currently taking medications that would mix poorly with ketamine

Why ketamine compliance is important

As ketamine therapy becomes more widely available, ensuring compliance with safety protocols is essential. While ketamine therapy may offer relief, improper administration — especially in at-home settings — can lead to serious health risks and treatment complications.

One major concern is the rise of at-home ketamine delivery companies with little oversight. Without proper medical supervision, patients may not be screened adequately for risk factors such as cardiovascular issues or substance use history. Blood pressure monitoring is a key safety measure, as ketamine can cause significant fluctuations in blood pressure and heart rate; in some, this could even lead to cardiac events. Patients using ketamine at home should have a trained support person present to assist in the drug’s administration.

Beyond physical safety, adherence to medical guidelines ensures optimal treatment outcomes. Ketamine is most effective when used as part of a structured treatment plan, including therapy and ongoing mental health support. Non-compliance — such as skipping doses or using unregulated sources — can reduce its benefits and increase the risk of dependency or misuse.

Ketamine also causes long-term damage to the bladder and urinary tract that can result in a condition known as ketamine bladder syndrome. This triggers decreased control of the bladder with incontinence. Ketamine bladder syndrome may also cause blood in the urine and ulcers in the bladder

As we discussed above, these potential dangers mean providers must adhere to strict requirements, like the ones listed above, before approving ketamine treatment. Providers who fail to follow the proper guidelines for care risk not only putting their patients at risk but also face fines, lawsuits, and loss of licensure.

Ultimately, ketamine compliance is about balancing innovation with responsibility. When administered safely and ethically, it can be a life-changing treatment for individuals who have exhausted other options. However, without proper safeguards, its potential benefits may be overshadowed by preventable risks.

Creating a ketamine compliance program

Now that we have a better understanding of ketamine therapy and the important of compliance, let’s review how to build a ketamine compliance program that will ensure your organization is providing safe care in line with governmental and/or accrediting bodies.

1. Establish oversight and documentation protocols

Spravato has a built-in reporting system that notifies providers and organizations when a dose is missed. This ensures that patients adhere to their prescribed regimen and allows providers to track treatment consistency. Accurate documentation of all dosing decisions and adjustments is critical, as it supports treatment planning, insurance approvals, and compliance with regulatory standards. For non-Spravato ketamine treatments, many clinics administer ketamine in-house, offering direct oversight from a provider.

2. Patient safety and monitoring requirements

At home ketamine is administered by the patient with little oversight, which makes compliance difficult. However, IV infusions must be administered by a healthcare professional due to the higher potency and rapid effects.

To keep your ketamine program in compliance, ensure your providers understand the following patient safety and monitoring best-practices.

State regulations typically require that a provider be on-site or within 20 minutes of the treatment location to address potential complications. Clinics should ensure that staff members are trained to recognize and manage side effects such as dizziness, nausea, dissociation, and elevated blood pressure.

Blood pressure monitoring is a critical safety measure, as ketamine can cause sudden increases in blood pressure. Best practices include:

• Blood pressure checks every 20 minutes during treatment.
• Documenting all readings to assess patient tolerance.
• Ensuring a support person is present for patients undergoing at-home treatments.

3. Regulatory compliance and CMS guidelines

While Medicare only covers Spravato and R-ketamine for anesthetics in SNF or hospitals, CMS guidelines for ketamine storage, handling, and disposal are a good blueprint to follow for creating an effective ketamine compliance program. As such, consider the following steps:

• Medications should be stored in temperature-controlled, secure areas to prevent degradation or unauthorized access.
• Compromised medications must be properly discarded following DEA and state regulations to prevent misuse or accidental ingestion.
• Additionally, behavioral health organizations offering ketamine therapy must comply with Medicare Part C and D requirements and maintain clear documentation of patient eligibility, dosing, and treatment outcomes.
• Follow strict record-keeping and reporting requirements for prescription drugs.
• Ensure transparency with patients, insurers, and regulatory agencies.

Routine audits and monitoring systems help ensure compliance with federal and state regulations. As such, your organization should:

• Conduct regular compliance audits to verify that treatment protocols align with legal and ethical standards.
• Address potential risks promptly to prevent regulatory violations.
• Maintain open communication with staff and government agencies to ensure compliance updates are followed.

4. Financial assistance and patient access

Many patients face financial barriers when accessing ketamine therapy. To improve affordability, Janssen offers a Spravato patient assistance program, which may provide eligible patients with up to one year of free medication if they meet the following criteria:

• Uninsured or covered by commercial/employer-sponsored insurance.
• Reside in the U.S. and receive outpatient care from a licensed provider.
• Prescribed an eligible Janssen medication and meet income requirements.
• Medicare Part D patients must:
  • Show they are not eligible for Low-Income Subsidy (LIS).
  • Spend more than 4% of their gross annual household income on prescription medications.

Providers should proactively inform patients about financial assistance options and help with applications to ensure treatment continuity.

Because Spravato requires a specialty pharmacy, providers should establish relationships with Janssen-approved specialty pharmacies to streamline access to medication. Specialty pharmacies assist with:

• Coordinating prior authorizations and insurance approvals.
• Managing prescription fulfillment and compliance tracking.
• Educating patients on proper medication use.

5. Training and ethical considerations

A successful ketamine compliance program requires well-trained staff and clear communication channels to ensure patient safety and regulatory adherence. Behavioral health organizations that offer this therapy should:

• Educate all employees on ketamine administration, safety protocols, and CMS compliance.
• Train providers and technicians on recognizing and managing side effects such as dissociation, blood pressure changes, and nausea.
• Establish clear communication between clinical staff, pharmacy partners, and relevant government agencies to ensure compliance and smooth treatment coordination.
• Enforce a Standards of Conduct policy, outlining expectations for ethical patient care and compliance with regulations.

Providers should ensure ketamine therapy is part of a comprehensive treatment plan, not a standalone intervention. Best practices include:

• Assessing for substance use history to determine whether ketamine therapy is appropriate.
• Integrating psychotherapy to help patients process their experiences and enhance long-term outcomes.
• Monitoring for long-term effects, such as potential bladder issues, and adjusting treatment plans accordingly.

By prioritizing staff training, ethical care, and transparent communication, behavioral health providers can offer safe, effective, and compliant ketamine therapy.